Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHINE: Bright White Light Therapy in Advanced Prostate Cancer
NCT05869682Phase 2Recruiting
- Sponsor
- City of Hope
- Start
- Jul 2024
- Primary completion
- Nov 2028
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by City of Hope. Primary endpoint: Patient-Reported Fatigue (FACIT-Fatigue) at 3 months. Started Jul 2024; status: recruiting.
Beyond the preview
Go deeper on NCT05869682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05869682.